Physician

Suresh Alla, M.D.

According to 2025 Medicare claims, Suresh Alla, M.D. (NPI: 1134339203) practices nephrology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is RENALCARE ASSOCIATES, S.C. (NPI: 1649300377; TIN: 370995483) and primary practice location at 61282-1621. Alla is affiliated with the OSF Healthcare System (ACO ID: A3289), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), SBL accountable care organization (ACO ID: A5147), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Alla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 577 traditional Medicare patients, billed 2,153 HCPCS/CPT codes, and received $137,028 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,249 prescription claims across 592 beneficiaries totaling $351,477 in drug costs, led by Jardiance (Empagliflozin). 2019 DME data shows 52 claims. Open Payments data shows 2 records totaling $33. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $445,517 to $137,028. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,033	21,281	$445,517
2016	840	9,954	$328,070
2017	904	7,516	$289,337
2018	874	2,033	$236,279
2019	976	1,910	$225,042
2020	829	1,681	$221,286
2021	822	1,971	$254,652
2022	664	1,904	$217,839
2023	618	1,516	$166,417
2024	577	2,153	$137,028

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	470	3,143	$259,443
2016	478	3,072	$472,994
2017	490	2,904	$604,210
2018	488	2,378	$270,876
2019	524	2,921	$276,004
2020	511	2,461	$302,934
2021	558	2,518	$256,800
2022	573	3,389	$255,516
2023	560	3,776	$296,569
2024	592	4,249	$351,477

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	17	$213
2016	N/R	71	$8,730
2017	N/R	34	$1,016
2018	N/R	54	$4,305
2019	N/R	52	$6,313
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	67	70	$124
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	48	97	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	114	314	$60
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	376	659	$54
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	388	702	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	137	7,662	$151,250
Farxiga	Dapagliflozin Propanediol	23	1,610	$31,128
Lokelma	Sodium Zirconium Cyclosilicate	30	906	$24,269
Lanthanum Carbonate	Lanthanum Carbonate	15	630	$16,554
Veltassa	Patiromer Calcium Sorbitex	12	445	$15,118

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$33	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Suresh Alla, M.D.?

Tedicare shows public-source Medicare data for Suresh Alla, M.D. (NPI 1134339203), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Suresh Alla, M.D. have ACO affiliation data?

Suresh Alla, M.D. is shown with ACO affiliation data for OSF Healthcare System (MSSP, ACO ID A3289), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), SBL accountable care organization (MSSP, ACO ID A5147), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Suresh Alla, M.D.?

Suresh Alla, M.D. is linked to RENALCARE ASSOCIATES, S.C. (billing NPI 1649300377) in the available physician profile data.

Does Suresh Alla, M.D. have Open Payments data?

Suresh Alla, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.